Prognostic value of simple blood biomarkers of systemic inflammation for metastatic renal cell carcinoma (mRCC) patients who undergo cytoreductive nephrectomy (CNx).

Jigi Moudgil-Joshi,Mark Stares,Alex Laird,Steve Leung,Jahangeer Malik,Aravindhan Sundaramurthy,Stefan Symeonides

Prognostic value of simple blood biomarkers of systemic inflammation for metastatic renal cell carcinoma (mRCC) patients who undergo cytoreductive nephrectomy (CNx).

2021

Jigi Moudgil-Joshi
Mark Stares
Alex Laird
Steve Leung
Jahangeer Malik
Aravindhan Sundaramurthy
Stefan Symeonides

350Background: The role of cytoreductive nephrectomy (CNx) in patients with metastatic renal cell carcinoma (mRCC) is currently in question. Assessing the benefits and risks of CNx is challenging, ...

Keywords:

Urology
blood biomarkers
in patient
Systemic inflammation
Renal cell carcinoma
cytoreductive nephrectomy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations